Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2025-12-24 @ 4:27 PM
NCT ID:
NCT04938466
Eligibility Criteria:
Inclusion Criteria:
* Girls must be between the ages of 2 and 11 years, and boys must be between the ages of 2 and 13 years
* Have established diagnosis of pediatric growth hormone deficiency (GHD). For the purposes of the study, GHD is defined as peak growth hormone response to clonidine/arginine stimulation testing of \<10 ng/mL
* Either treatment-naive or currently treated with a daily growth hormone as approved by health insurance
Exclusion Criteria:
* Any medical condition which, in the opinion of the Investigator, can be an independent cause of short stature and/or limit the response to exogenous growth factor treatment
* Current treatment with long-acting growth hormone
* Currently pregnant or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
13 Years
Study:
NCT04938466
Study Brief:
Protocol Section:
NCT04938466